BIOS‑0629
/ Hangzhou Bio-Sincerity Pharma-Tech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 13, 2025
Hangzhou Bio‑Sincerity Pharma‑Tech…announced that the company has signed a Technology Development Cooperation Agreement with Zhejiang Zhongshen Innovation Pharmaceutical Technology Co., Ltd. for its in‑house drug BIOS‑0629, a second‑generation Nuclear Export Protein 1 (XPO1) inhibitor
(flcube.com)
Licensing / partnership • Solid Tumor
1 to 1
Of
1
Go to page
1